MARATTO

article · Bulletin of the National Research Centre/Bulletin of the National Research Center

Clinical samples with delayed processing time are associated with lower HIV viral load results in a high-volume regional laboratory, Njombe Region, Tanzania (Oct 2024–Mar 2025)

Abstract

Abstract Background Accurate HIV viral load (VL) testing is essential for monitoring antiretroviral therapy (ART) and detecting treatment failure. In resource-limited settings such as Njombe Region, Tanzania, laboratories often face prolonged turnaround times (TAT) and suboptimal sample transport and storage. While RNA degradation during extended storage is well documented, its impact on routine, high-volume VL testing remains unclear. This study quantified the association between laboratory processing delays and reported HIV VL results. Methods We conducted a cross-sectional secondary analysis of VL data from Njombe Town Council Hospital Laboratory (October 2024–March 2025, N = 18,271). After excluding 244 records with missing dates, 18,025 samples were analyzed. Three TAT intervals—collection-to-reception (clinic to lab), reception-to-registration (lab receipt to system entry), and registration-to-testing (system entry to assay performance)—were categorized into quartiles. Multivariable multinomial logistic regression with predictive margins estimated associations between TAT delays and VL categories. Results Median total TAT was 22 days (IQR 13–36), exceeding the recommended ≤ 14 days. Only the slowest registration-to-testing quartile (Q4: ≥21 days) showed consistently fewer detectable VL results. Adjusted probability of Target Not Detected (TND) increased from 71.2% (fastest quartile) to 85.8% (slowest quartile) (RR = 1.205; 95% CI: 1.196–1.214; p < 0.001), while probabilities for all detectable VL categories declined significantly. Conclusion Prolonged registration-to-testing delays were strongly associated with lower reported HIV VL results, consistent with RNA degradation or pre-analytical bias. Such delays may compromise patient care and program monitoring. Therefore, interventions targeting workflow and laboratory system optimization are warranted—a conclusion likely generalizable to similar centralized HIV viral load laboratories across low- and middle-income countries.

Research topics

  • HIV/AIDS Research and Interventions
  • Clinical Laboratory Practices and Quality Control
  • SARS-CoV-2 detection and testing

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1186/s42269-026-01478-9

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.